GlassScriptPhysician profile
Erin Tuemler
NPI 1902190366
$1,460.68
in general payments reported to CMS, 2019-2025
25 companies · $242 in 2025
The $242 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $164 · 2021: $40.96 · 2022: $185 · 2023: $174 · 2024: $283 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $698.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $399.35 | 2019-2022 | |
| Astellas Pharma US INC | $203.20 | 2023-2025 | Veozah |
| Merck Sharp & Dohme LLC | $84.56 | 2019-2024 | Gardasil 9, Gardasil |
| Sage Therapeutics, LLC | $67.89 | 2024-2025 | Zurzuvae |
| Avion Pharmaceuticals | $67.62 | 2019-2022 | |
| Channel Medsystems, INC. | $65.37 | 2023 | |
| Organon LLC | $62.30 | 2022-2024 | |
| Meditrina | $51.26 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $45.67 | 2023-2024 | Myfembree |
| Millicent US INC | $40.02 | 2025 | Femlyv |
| Ethicon US, LLC | $38.82 | 2025 | Vistaseal, Ethicon, Stratafix |
| Innovation Technologies INC | $32.54 | 2024 | Irrisept |
| Mayne Pharma Commercial LLC | $30.38 | 2022 | |
| Duchesnay USA Incorporated | $29.47 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.15 | 2019-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $27.96 | 2019 | |
| Amag Pharmaceuticals, INC. | $27.22 | 2019 | |
| Pfizer INC. | $24.28 | 2022 | |
| Supernus Pharmaceuticals, INC. | $23.75 | 2025 | Qelbree |
| Shield Therapeutics INC | $22.52 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $21.75 | 2025 | Exparel |
| Hologic Sales and Service, LLC | $20.90 | 2023 | Aptima, Thinprep 2000 Processor |
| Novo Nordisk INC | $17.25 | 2024 | Wegovy |
| Avanos Medical | $15.69 | 2019 | |
| Minerva Surgical, INC | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Tuemler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.